PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 54 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,810 | -31.3% | 70,165 | 0.0% | 0.00% | – |
| Q2 2023 | $315,743 | +61.5% | 70,165 | +104.6% | 0.00% | – |
| Q1 2023 | $195,499 | +2.3% | 34,298 | 0.0% | 0.00% | – |
| Q4 2022 | $191,135 | -14.5% | 34,298 | +0.1% | 0.00% | – |
| Q3 2022 | $223,500 | +25.9% | 34,267 | 0.0% | 0.00% | – |
| Q2 2022 | $177,538 | -25.5% | 34,267 | 0.0% | 0.00% | – |
| Q1 2022 | $238,445 | -0.2% | 34,267 | +521.2% | 0.00% | – |
| Q1 2021 | $239,000 | -36.8% | 5,516 | +4.3% | 0.00% | – |
| Q4 2020 | $378,000 | – | 5,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $66,362,000 | 1.23% |
| Baker Brothers Advisors | 10,123,824 | $66,918,000 | 0.44% |
| HHLR ADVISORS, LTD. | 583,333 | $3,856,000 | 0.10% |
| CAXTON ASSOCIATES LP | 85,992 | $568,000 | 0.08% |
| Virtus ETF Advisers LLC | 24,180 | $160,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 54,173 | $358,000 | 0.05% |
| DENALI ADVISORS LLC | 8,200 | $54,000 | 0.03% |
| PDT Partners, LLC | 12,641 | $84,000 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS INC | 2,402,595 | $15,881,153,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $244,000 | 0.01% |